Ofatumumab for B cell depletion therapy in ANCA-associated vasculitis: a single-centre case series

Objectives. B cell depletion is an effective treatment strategy in ANCA-associated vasculitis (AAV). Ofatumumab is a fully humanized anti-CD20 mAb that has shown efficacy in the treatment of haematological malignancy and RA. The use of ofatumumab in the treatment of AAV has not previously been repor...

Descripción completa

Detalles Bibliográficos
Autores principales: McAdoo, Stephen P., Bedi, Rachna, Tarzi, Ruth, Griffith, Megan, Pusey, Charles D., Cairns, Thomas D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957674/
https://www.ncbi.nlm.nih.gov/pubmed/27094598
http://dx.doi.org/10.1093/rheumatology/kew199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957674/
https://www.ncbi.nlm.nih.gov/pubmed/27094598
http://dx.doi.org/10.1093/rheumatology/kew199

Ejemplares similares